FDA 483 - Janssen Ortho LLC - August 28, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Janssen Ortho LLC in Gurabo, PR, received a Form 483 for significant deficiencies in laboratory controls, manufacturing process monitoring, and investigation practices. The inspection revealed issues with chromatographic data integrity, failure to identify root causes for dissolution rate variability in Invokana tablets, and the release of Invokamet lots with unresolved dissolution failures. These observations indicate a lack of robust quality control and investigation procedures impacting drug product quality and assurance.
ID · 7d33606c-84b5-4040-ba37-a1042b2ddd77